Exact Mass: 1292.6494616

Exact Mass Matches: 1292.6494616

Found 16 metabolites which its exact mass value is equals to given mass value 1292.6494616, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

[(3S,10S,11S,12S,13S,14S)-17-acetyl-11-acetyloxy-14-hydroxy-3-[5-[5-[5-[3-hydroxy-4-methoxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-12-yl] (E)-3-phenylprop-2-enoate

[(3S,10S,11S,12S,13S,14S)-17-acetyl-11-acetyloxy-14-hydroxy-3-[5-[5-[5-[3-hydroxy-4-methoxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-12-yl] (E)-3-phenylprop-2-enoate

C66H100O25 (1292.655335)

Hexaalbaspidin

C73H96O20 (1292.6494616)

3-O-[beta-D-glucopyranosyl(1->2)]-[alpha-L-arabinopyranosyl(1->3)]-[alpha-L-arabinofuranosyl(1->4)]-beta-D-glucuronopyranosyl-21-(2-acetoxy-2-methylbutanoyl)-22-acetyl-R1-barrigenol|saponin IIIA2

C61H96O29 (1292.6036966)

C61H96O29

C61H96O29 (1292.6036966)

C61H96O29_Butanoic acid, 2-(acetyloxy)-2-methyl-, (3beta,5xi,9xi,15alpha,16alpha,21beta,22alpha)-22-(acetyloxy)-3-[[O-alpha-L-arabinopyranosyl-(1->3)-O-alpha-L-arabinopyranosyl-(1->3)-O-[beta-D-glucopyranosyl-(1->2)]-beta-D-glucopyranuronosyl]oxy]-15,16,28-trihydroxyolean-12-en-21-yl ester

NCGC00380121-01_C61H96O29_Butanoic acid, 2-(acetyloxy)-2-methyl-, (3beta,5xi,9xi,15alpha,16alpha,21beta,22alpha)-22-(acetyloxy)-3-[[O-alpha-L-arabinopyranosyl-(1->3)-O-alpha-L-arabinopyranosyl-(1->3)-O-[beta-D-glucopyranosyl-(1->2)]-beta-D-glucopyranuronosyl]oxy]-15,16,28-trihydroxyolean-12-en-21-yl ester

C61H96O29 (1292.6036966)

C66H100O25_2-Propenoic acid, 3-phenyl-, (3beta,8xi,9xi,11alpha,12beta,14beta,17xi)-11-(acetyloxy)-3-[[O-hexopyranosyl-(1->4)-O--6-deoxy-3-O-methylhexopyranosyl-(1->4)-O--2,6-dideoxy-3-O-methylhexopyranosyl-(1->4)-O--2,6-dideoxy-3-O-methylhexopyranosyl-(1->4)-2,6-dideoxy-3-O-methylhexopyranosyl]oxy]-14-hydroxy-20-oxopregnan-12-yl ester, (2E)

NCGC00381211-01_C66H100O25_2-Propenoic acid, 3-phenyl-, (3beta,8xi,9xi,11alpha,12beta,14beta,17xi)-11-(acetyloxy)-3-[[O-hexopyranosyl-(1->4)-O--6-deoxy-3-O-methylhexopyranosyl-(1->4)-O--2,6-dideoxy-3-O-methylhexopyranosyl-(1->4)-O--2,6-dideoxy-3-O-methylhexopyranosyl-(1->4)-2,6-dideoxy-3-O-methylhexopyranosyl]oxy]-14-hydroxy-20-oxopregnan-12-yl ester, (2E)-

C66H100O25 (1292.655335)

[(3S,10S,11S,12S,13S,14S)-17-acetyl-11-acetyloxy-14-hydroxy-3-[5-[5-[5-[3-hydroxy-4-methoxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-12-yl] (E)-3-phenylprop-2-enoate_major

C66H100O25 (1292.655335)

[(3S,10S,11S,12S,13S,14S)-17-acetyl-11-acetyloxy-14-hydroxy-3-[5-[5-[5-[3-hydroxy-4-methoxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-12-yl] (E)-3-phenylprop-2-enoate_42.4\\%

C66H100O25 (1292.655335)

[(3S,10S,11S,12S,13S,14S)-17-acetyl-11-acetyloxy-14-hydroxy-3-[5-[5-[5-[3-hydroxy-4-methoxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-12-yl] (E)-3-phenylprop-2-enoate_29.4\\%

C66H100O25 (1292.655335)

[(3S,10S,11S,12S,13S,14S)-17-acetyl-11-acetyloxy-14-hydroxy-3-[5-[5-[5-[3-hydroxy-4-methoxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-12-yl] (E)-3-phenylprop-2-enoate_90.6\\%

C66H100O25 (1292.655335)

[(3S,10S,11S,12S,13S,14S)-17-acetyl-11-acetyloxy-14-hydroxy-3-[5-[5-[5-[3-hydroxy-4-methoxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-12-yl] (E)-3-phenylprop-2-enoate_12.3\\%

C66H100O25 (1292.655335)

(3?,8?,9?,11?,12?,14?,17?)-11-Acetoxy-3-{[hexopyranosyl-(1->4)-6-deoxy-3-O-methylhexopyranosyl-(1->4)-2,6-dideoxy-3-O-methylhexopyranosyl-(1->4)-2,6-dideoxy-3-O-methylhexopyranosyl-(1- >4)-2,6-dideoxy-3-O-methylhexopyranosyl]oxy}-14-hydroxy-20-oxopregnan-12-yl (2E)-3-phenylacrylate

(3?,8?,9?,11?,12?,14?,17?)-11-Acetoxy-3-{[hexopyranosyl-(1->4)-6-deoxy-3-O-methylhexopyranosyl-(1->4)-2,6-dideoxy-3-O-methylhexopyranosyl-(1->4)-2,6-dideoxy-3-O-methylhexopyranosyl-(1- >4)-2,6-dideoxy-3-O-methylhexopyranosyl]oxy}-14-hydroxy-20-oxopregnan-12-yl (2E)-3-phenylacrylate

C66H100O25 (1292.655335)

PIM3 32:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C59H105O28P (1292.652966)

MBP (1-11), guinea pig, porcine, rabbit, rat, Myelin Basic Protein (135-145), human,Ac-ASQKRPSQRHG

C52H88N22O17 (1292.6697478)

Breviscapine

C54H84N16O21 (1292.5996654)

Breviscapine is a crude flavonoid extract of Breviscapine, which is more than 85\\% of the active ingredient, Breviscapine. Breviscapine has a wide range of cardiovascular pharmacological activities, such as increasing blood flow, improving microcirculation, dilating blood vessels, reducing blood viscosity, promoting fibrinolysis, inhibiting platelet aggregation and thrombosis. Breviscapine has been used in the study of cerebral infarction and its sequelae, cerebral thrombosis, coronary heart disease and angina pectoris[1][2]. Breviscapine is a crude flavonoid extract of Breviscapine, which is more than 85\% of the active ingredient, Breviscapine. Breviscapine has a wide range of cardiovascular pharmacological activities, such as increasing blood flow, improving microcirculation, dilating blood vessels, reducing blood viscosity, promoting fibrinolysis, inhibiting platelet aggregation and thrombosis. Breviscapine has been used in the study of cerebral infarction and its sequelae, cerebral thrombosis, coronary heart disease and angina pectoris[1][2].

Lanolin

C54H84N16O21 (1292.5996654)

Lanolin is a yellow fat obtained from sheep's wool. Lanolin is used topically for sore, cracked nipples during breastfeeding[1].